【摘要】 目的：探讨冠心病并发心力衰竭患者实施美托洛尔联合盐酸曲美他嗪治疗的临床效果。方法：纳入2017年6月-2018年6月笔者所在医院收治的冠心病并发心力衰竭患者92例作为研究对象，按随机数字表法分为试验组(46例)、对照组(46例)，试验组：美托洛尔+盐酸曲美他嗪治疗，对照组：美托洛尔治疗，对比两组心功能、血清BNP水平、炎症因子水平。结果：试验组心功能水平均优于对照组，差异有统计学意义(P<0.05)。试验组血清BNP水平优于对照组，差异有统计学意义(P<0.05)。试验组炎症因子水平均低于对照组，差异有统计学意义(P<0.05)。结论：冠心病并发心力衰竭患者实施美托洛尔联合盐酸曲美他嗪治疗的临床效果显著，可明显改善患者心功能，值得临床治疗借鉴。

    【关键词】 美托洛尔; 盐酸曲美他嗪; 冠心病; 心力衰竭; 临床效果

    doi：10.14033/j.cnki.cfmr.2019.15.010 文献标识码 B 文章编号 1674-6805(2019)15-00-03

    【Abstract】 Objective：To investigate the clinical effect of Metoprolol combined with Trimetazidine Hydrochloride in patients with coronary heart disease complicated with heart failure.Method：A total of 92 patients with coronary heart disease complicated with heart failure admitted in our hospital from June 2017 to June 2018 were enrolled in the study.They were divided into experimental group(46 cases) and control group(46 cases) according to random number table.Experimental group：Metoprolol+Trimetazidine Hydrochloride treatment ......